Beacon Pointe Advisors, LLC
- SEC CIK
- 0001744317
- Latest filing
- Aug 18, 2026
BMRN holding history
Biomarin Pharmaceutical Inc in every 13F filed by Beacon Pointe Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −4,316−100.0% | Sold out | Holders |
| Q2 2025 | 4,316 | $237.3K | <0.1% | −2,847−39.7% | Reduced | Holders |
| Q1 2025 | 7,163 | $506.4K | <0.1% | +1,399+24.3% | Added | Holders |
| Q4 2024 | 5,764 | $378.9K | <0.1% | −4,906−46.0% | Reduced | Holders |
| Q3 2024 | 10,670 | $750.0K | <0.1% | +526+5.2% | Added | Holders |
| Q2 2024 | 10,144 | $835.2K | <0.1% | −4,466−30.6% | Reduced | Holders |
| Q1 2024 | 14,610 | $1.28M | <0.1% | −3,228−18.1% | Reduced | Holders |
| Q4 2023 | 17,838 | $1.72M | <0.1% | −133−0.7% | Reduced | Holders |
| Q3 2023 | 17,971 | $1.59M | <0.1% | −356−1.9% | Reduced | Holders |
| Q2 2023 | 18,327 | $1.59M | <0.1% | −729−3.8% | Reduced | Holders |
| Q1 2023 | 19,056 | $1.85M | <0.1% | +1,372+7.8% | Added | Holders |
| Q4 2022 | 17,684 | $1.83M | <0.1% | +2,645+17.6% | Added | Holders |
| Q3 2022 | 15,039 | $1.27M | <0.1% | −253−1.7% | Reduced | Holders |
| Q2 2022 | 15,292 | $1.27M | <0.1% | −1,125−6.9% | Reduced | Holders |
| Q1 2022 | 16,417 | $1.27M | <0.1% | +1,499+10.0% | Added | Holders |
| Q4 2021 | 14,918 | $1.32M | <0.1% | −1,764−10.6% | Reduced | Holders |
| Q3 2021 | 16,682 | $1.29M | <0.1% | +9,260+124.8% | Added | Holders |
| Q2 2021 | 7,422 | $619.0K | <0.1% | +7,422 | New | Holders |